 Veronica Alaniz
Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anorectal Malformations | 7 | 2023 | 102 | 2.790 |
Why?
| | Gynecology | 6 | 2022 | 163 | 1.880 |
Why?
| | Vagina | 6 | 2023 | 146 | 1.340 |
Why?
| | Transgender Persons | 2 | 2022 | 134 | 1.330 |
Why?
| | Urogenital Abnormalities | 3 | 2023 | 47 | 1.160 |
Why?
| | Congenital Abnormalities | 3 | 2022 | 72 | 1.070 |
Why?
| | Hymen | 2 | 2022 | 5 | 0.850 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2023 | 23 | 0.840 |
Why?
| | Leuprolide | 1 | 2022 | 19 | 0.820 |
Why?
| | 46, XX Disorders of Sex Development | 1 | 2022 | 6 | 0.810 |
Why?
| | Disabled Persons | 1 | 2023 | 130 | 0.750 |
Why?
| | Vulvar Lichen Sclerosus | 1 | 2020 | 1 | 0.730 |
Why?
| | Vulvovaginitis | 1 | 2020 | 1 | 0.730 |
Why?
| | Contraceptive Agents, Female | 1 | 2021 | 64 | 0.720 |
Why?
| | Kidney Diseases | 1 | 2023 | 349 | 0.690 |
Why?
| | Genital Diseases, Female | 2 | 2019 | 25 | 0.680 |
Why?
| | Disorders of Sex Development | 2 | 2019 | 34 | 0.670 |
Why?
| | Gonadal Dysgenesis | 2 | 2017 | 8 | 0.670 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2022 | 213 | 0.670 |
Why?
| | Colitis, Ulcerative | 1 | 2021 | 104 | 0.660 |
Why?
| | Symptom Assessment | 1 | 2020 | 119 | 0.660 |
Why?
| | Lichen Sclerosus et Atrophicus | 1 | 2019 | 3 | 0.660 |
Why?
| | Coitus | 1 | 2019 | 27 | 0.640 |
Why?
| | Urethra | 1 | 2019 | 48 | 0.620 |
Why?
| | Female | 32 | 2023 | 59324 | 0.560 |
Why?
| | Breast Cyst | 1 | 2017 | 2 | 0.560 |
Why?
| | Vulvar Diseases | 3 | 2022 | 10 | 0.530 |
Why?
| | Gonads | 1 | 2016 | 21 | 0.530 |
Why?
| | Breast | 1 | 2017 | 138 | 0.530 |
Why?
| | Adolescent | 17 | 2023 | 17800 | 0.520 |
Why?
| | Young Adult | 11 | 2023 | 10444 | 0.520 |
Why?
| | Hyperemesis Gravidarum | 1 | 2015 | 4 | 0.500 |
Why?
| | Cannabinoids | 1 | 2015 | 115 | 0.440 |
Why?
| | Ultrasonography | 1 | 2016 | 635 | 0.410 |
Why?
| | Humans | 32 | 2023 | 114045 | 0.390 |
Why?
| | Marijuana Smoking | 1 | 2015 | 224 | 0.390 |
Why?
| | Adolescent Medicine | 2 | 2022 | 33 | 0.370 |
Why?
| | Internship and Residency | 4 | 2022 | 920 | 0.370 |
Why?
| | Child | 13 | 2023 | 18401 | 0.360 |
Why?
| | Pregnancy Outcome | 2 | 2023 | 337 | 0.360 |
Why?
| | Retrospective Studies | 9 | 2023 | 12521 | 0.350 |
Why?
| | Adult | 12 | 2023 | 30375 | 0.340 |
Why?
| | Cloaca | 2 | 2021 | 47 | 0.330 |
Why?
| | Pediatrics | 3 | 2022 | 982 | 0.320 |
Why?
| | Gynecologic Surgical Procedures | 3 | 2021 | 44 | 0.260 |
Why?
| | Hematometra | 2 | 2023 | 6 | 0.260 |
Why?
| | Uterus | 2 | 2023 | 191 | 0.250 |
Why?
| | Ulcer | 2 | 2022 | 28 | 0.250 |
Why?
| | Magnetic Resonance Imaging | 1 | 2016 | 3039 | 0.240 |
Why?
| | Pregnancy | 6 | 2023 | 5499 | 0.230 |
Why?
| | Hematocolpos | 1 | 2023 | 3 | 0.210 |
Why?
| | Gynecological Examination | 1 | 2022 | 4 | 0.210 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 4402 | 0.210 |
Why?
| | Mullerian Ducts | 1 | 2022 | 8 | 0.210 |
Why?
| | Stomatitis, Aphthous | 1 | 2022 | 10 | 0.200 |
Why?
| | Fertility | 1 | 2023 | 128 | 0.200 |
Why?
| | Child, Preschool | 4 | 2020 | 9114 | 0.200 |
Why?
| | Dilatation | 1 | 2022 | 58 | 0.200 |
Why?
| | Goals | 1 | 2023 | 145 | 0.200 |
Why?
| | Menstrual Cycle | 1 | 2022 | 108 | 0.200 |
Why?
| | Desogestrel | 1 | 2021 | 40 | 0.190 |
Why?
| | Personal Satisfaction | 1 | 2023 | 181 | 0.190 |
Why?
| | Drug Implants | 1 | 2021 | 70 | 0.190 |
Why?
| | Delayed Diagnosis | 2 | 2019 | 71 | 0.190 |
Why?
| | Colon, Sigmoid | 1 | 2021 | 15 | 0.180 |
Why?
| | Hormones | 1 | 2021 | 132 | 0.180 |
Why?
| | Hirschsprung Disease | 1 | 2022 | 90 | 0.180 |
Why?
| | Curriculum | 3 | 2022 | 813 | 0.180 |
Why?
| | Tamoxifen | 1 | 2021 | 190 | 0.180 |
Why?
| | Michigan | 1 | 2020 | 95 | 0.180 |
Why?
| | Developmental Disabilities | 1 | 2023 | 236 | 0.180 |
Why?
| | Pain | 2 | 2023 | 701 | 0.170 |
Why?
| | Virus Diseases | 1 | 2022 | 195 | 0.170 |
Why?
| | Constriction, Pathologic | 1 | 2021 | 207 | 0.170 |
Why?
| | Kidney | 2 | 2023 | 1182 | 0.170 |
Why?
| | Obstetrics | 1 | 2022 | 146 | 0.170 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 126 | 0.170 |
Why?
| | Clobetasol | 1 | 2019 | 4 | 0.170 |
Why?
| | Simulation Training | 1 | 2020 | 62 | 0.160 |
Why?
| | Triamcinolone | 1 | 2019 | 14 | 0.160 |
Why?
| | Educational Measurement | 2 | 2020 | 235 | 0.160 |
Why?
| | Ointments | 1 | 2019 | 23 | 0.160 |
Why?
| | Testosterone | 1 | 2022 | 341 | 0.160 |
Why?
| | Vaginal Diseases | 1 | 2019 | 17 | 0.160 |
Why?
| | Early Detection of Cancer | 1 | 2022 | 305 | 0.160 |
Why?
| | Dilatation, Pathologic | 1 | 2019 | 55 | 0.160 |
Why?
| | Middle Aged | 4 | 2023 | 26605 | 0.160 |
Why?
| | Genitalia, Female | 1 | 2018 | 37 | 0.150 |
Why?
| | Diagnostic Errors | 1 | 2019 | 150 | 0.150 |
Why?
| | Transition to Adult Care | 1 | 2018 | 60 | 0.140 |
Why?
| | Hemorrhage | 1 | 2021 | 600 | 0.140 |
Why?
| | Sex Differentiation | 1 | 2017 | 11 | 0.140 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 2017 | 14 | 0.140 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 478 | 0.140 |
Why?
| | Prospective Studies | 3 | 2023 | 6195 | 0.140 |
Why?
| | Caregivers | 1 | 2023 | 713 | 0.130 |
Why?
| | Castration | 1 | 2016 | 14 | 0.130 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2016 | 6 | 0.130 |
Why?
| | Cysts | 1 | 2017 | 92 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2022 | 592 | 0.130 |
Why?
| | Perinatal Care | 1 | 2016 | 36 | 0.130 |
Why?
| | Abortion, Induced | 1 | 2017 | 71 | 0.130 |
Why?
| | Adolescent Health Services | 1 | 2016 | 68 | 0.130 |
Why?
| | Pregnancy in Adolescence | 1 | 2016 | 79 | 0.120 |
Why?
| | Baths | 1 | 2015 | 17 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1331 | 0.120 |
Why?
| | Glucocorticoids | 1 | 2019 | 526 | 0.120 |
Why?
| | Male | 7 | 2022 | 55396 | 0.120 |
Why?
| | Clinical Competence | 1 | 2020 | 882 | 0.110 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2016 | 227 | 0.110 |
Why?
| | Mental Health Services | 1 | 2016 | 316 | 0.100 |
Why?
| | Aged, 80 and over | 1 | 2022 | 6306 | 0.100 |
Why?
| | Patient Acceptance of Health Care | 1 | 2017 | 675 | 0.100 |
Why?
| | Patient-Centered Care | 1 | 2016 | 470 | 0.090 |
Why?
| | Cohort Studies | 1 | 2020 | 4883 | 0.090 |
Why?
| | Mothers | 1 | 2016 | 650 | 0.090 |
Why?
| | Time Factors | 1 | 2020 | 6077 | 0.090 |
Why?
| | Aged | 1 | 2022 | 18969 | 0.060 |
Why?
| | Databases, Factual | 2 | 2019 | 1125 | 0.060 |
Why?
| | Vaccination | 2 | 2022 | 1202 | 0.060 |
Why?
| | Radiology, Interventional | 1 | 2023 | 26 | 0.050 |
Why?
| | Urogenital System | 1 | 2022 | 18 | 0.050 |
Why?
| | Drainage | 1 | 2023 | 145 | 0.050 |
Why?
| | Vulva | 1 | 2022 | 24 | 0.050 |
Why?
| | United States | 3 | 2022 | 12137 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2020 | 259 | 0.040 |
Why?
| | Hydrocolpos | 1 | 2019 | 5 | 0.040 |
Why?
| | Perineum | 1 | 2019 | 25 | 0.040 |
Why?
| | Genitalia | 1 | 2019 | 28 | 0.040 |
Why?
| | Rectal Prolapse | 1 | 2018 | 19 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 4595 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 19 | 0.040 |
Why?
| | Urologic Diseases | 1 | 2018 | 35 | 0.040 |
Why?
| | Colorado | 2 | 2018 | 4090 | 0.040 |
Why?
| | Digestive System Surgical Procedures | 1 | 2018 | 91 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 224 | 0.040 |
Why?
| | Fecal Incontinence | 1 | 2018 | 73 | 0.040 |
Why?
| | Abortifacient Agents, Steroidal | 1 | 2017 | 4 | 0.040 |
Why?
| | Dilatation and Curettage | 1 | 2017 | 10 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2018 | 2122 | 0.040 |
Why?
| | Lost to Follow-Up | 1 | 2017 | 20 | 0.040 |
Why?
| | Mifepristone | 1 | 2017 | 60 | 0.040 |
Why?
| | Pregnancy Trimester, Second | 1 | 2017 | 66 | 0.040 |
Why?
| | Reoperation | 1 | 2019 | 513 | 0.030 |
Why?
| | Reference Values | 1 | 2018 | 739 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1447 | 0.030 |
Why?
| | Pedigree | 1 | 2017 | 460 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2017 | 237 | 0.030 |
Why?
| | Depression, Postpartum | 1 | 2016 | 101 | 0.030 |
Why?
| | Program Development | 1 | 2016 | 339 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2020 | 2764 | 0.030 |
Why?
| | Parenting | 1 | 2016 | 252 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1310 | 0.030 |
Why?
| | Program Evaluation | 1 | 2016 | 820 | 0.020 |
Why?
| | Mental Health | 1 | 2016 | 559 | 0.020 |
Why?
| | Parents | 1 | 2017 | 1181 | 0.020 |
Why?
| | Physicians | 1 | 2017 | 765 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 5038 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 3338 | 0.020 |
Why?
| | Infant | 1 | 2019 | 7943 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9049 | 0.020 |
Why?
|
|
Alaniz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|